Business
Open Market Transactions (CEO & Director) - VRHI
Open Market Transactions (CEO & Director) - VRHI.
About this update from Veri Medtech Holdings Inc.
[{"type":"text","content":"VERI MEDTECH (VRHI) Announces CEO & Director Purchase: 7,953 Additional Shares of VRHI Stock in Open Market Transactions\r\n \r\nNEW YORK, August 22, 2025 - OTC Markets -- Veri Medtech\r\nHoldings, Inc. (Stock Ticker Symbol: “VRHI”) (\"Veri Medtech\"),\r\nhealthcare\r\ntechnology platform, announced today that via open market transactions: (1) Sam\r\nAdetunji, CEO, completed the purchase of an additional 6,000 shares of VRHI stock at an\r\naverage price per share of $0.98; and (2) Danny Wilson, Director, completed the\r\npurchase of an additional 1,953 shares of VRHI stock at an average price per share of $0.9387 per\r\nshare, for a combined total of: 7,953 shares. With these\r\npurchases, Mr. Adetunji beneficially owns 7,643,385 shares and Mr. Wilson beneficially owns: 491,876 shares of VRHI stock. \r\nQ2 Key Accomplishments:\r\n\r\n $2.86\r\n Million in Revenue\r\n Initiated\r\n Audit Process with PCAOB Auditor (in preparation for uplisting)\r\n Relaunched\r\n www.VeriMedTech.com \r\n Engaged\r\n in Discussions for Accretive Opportunities in Mergers/Acquisitions\r\n (Healthcare Technology Companies)\r\n\r\n \r\nAbout Veri Medtech (OTC Markets: VRHI): Veri Medtech\r\nis a publicly-traded healthcare technology company that offers alternative\r\nmedicine, personalized diagnostics, and wellness medication on demand. The\r\ncompany leverages telehealth infrastructure, diagnostic intelligence, and\r\nscalable digital systems to meet the growing demand for accessible, stigma-free\r\nhealthcare. Strategically positioned for growth, Veri MedTech actively explores\r\nacquisitions that complement its core capabilities and enhance patient engagement\r\nacross emerging sectors of alternative medicine, longevity, and wellness\r\nscience. With a strong integration and operational efficiency track record, the\r\ncompany drives accelerated revenue through the continuous generation of\r\nhigh-value patient databases and recurring service models. With a commitment to\r\ninnovation and patient-centric care, Veri MedTech continues to expand its\r\nservices and reach, aiming to make personalized healthcare more accessible and\r\neffective for all. For more information, please visit: www.VeriMedTech.com\r\nAbout Veriheal: Veriheal, a wholly-owned subsidiary\r\nof publicly-traded Veri M...